Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients.
about
Evidence-based treatments for cluster headacheNeuronal signal substances as biomarkers of migraineHeadache-type adverse effects of NO donors: vasodilation and beyondReliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches.New therapeutic target in primary headaches - blocking theCGRP receptor.Neurobiology of chronic tension-type headache.Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache.Release of PACAP-38 in episodic cluster headache patients - an exploratory study.Calcitonin gene-related peptide in blood: is it increased in the external jugular vein during migraine and cluster headache? A review.Methylprednisolone blocks interleukin 1 beta induced calcitonin gene related peptide release in trigeminal ganglia cellsNovel migraine therapy with calcitonin gene-regulated peptide receptor antagonists.Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal modelCGRP in human models of primary headaches.CGRP in migraine.Two cases of cluster headache effectively treated with levetiracetam.Simultaneous determination of three alkaloids, four ginsenosides and limonin in the plasma of normal and headache rats after oral administration of Wu-Zhu-Yu decoction by a novel ultra fast liquid chromatography-tandem mass spectrometry method: applIncreased plasma nitrites in migraine and cluster headache patients in interictal period: basal hyperactivity of L-arginine-NO pathway?Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emission tomography and transcranial Doppler.Platelet aggregation profiles in cluster headache.Nociceptive-specific blink reflex and glyceryl trinitrate infusion in healthy volunteers.Nitric oxide pathway and response to nitroglycerin in cluster headache patients: plasma nitrite and citrulline levels.Periods of cluster headache induced by nitrate therapy and spontaneous remission of angina pectoris during active clusters.Release of calcitonin gene-related peptide (CGRP) from guinea pig dura mater in vitro is inhibited by sumatriptan but unaffected by nitric oxide.Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks.Peripheral provocation of cranial autonomic symptoms is not sufficient to trigger cluster headache attacks.Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.Hyperbaric oxygen treatment of active cluster headache: a double-blind placebo-controlled cross-over study.Cluster headache: new targets and options for treatment.Therapeutic Approaches for the Management of Trigeminal Autonomic Cephalalgias.OnabotulinumtoxinA in the treatment of refractory chronic cluster headache.Corticosteroids alter CGRP and melatonin release in cluster headache episodesInduction of Nitrate Tolerance is not a Useful Treatment in Cluster Headache
P2860
Q26774849-EBCA0888-075E-46C0-BBB7-62B940D91F5AQ28254002-0B2ACD19-1B0A-4B73-B6C0-04E8B522B5D8Q33812736-A6EC160D-711D-47EF-9325-CF634C046508Q34544624-1192B5CA-E96C-4BB0-9612-C6A6F0BFB658Q35143902-B904EBCC-4C40-4EB3-AEFA-A16573AEB17EQ35685806-3AC16D57-5945-4600-9955-CA551383B3E8Q35841612-00A95108-1F68-403B-BABE-2027CD9E7A76Q36090751-5A3B84C4-C00B-44F7-A16E-D3C3E65B540FQ36260321-00FD32E4-DB68-4E5C-AE34-A61D95B95038Q36636845-34910280-B47D-4405-965D-C54A562B5A1DQ36936344-C092F0C1-1D28-4105-A2AC-D6AC90E289DFQ37716463-62086E8C-D0CB-478A-9FCB-9A7C087C53A5Q38784420-FA0C7578-CD48-450F-9212-515D8407E715Q42327514-D4D62E4D-41CD-44CE-B222-0371F5957945Q42928452-3B6B5F42-1DA4-4245-8E23-1F13B649512EQ43632833-FBD36F15-2B9C-4351-921A-7E2FD1A152C8Q43981820-CF27A4A9-BFE8-42D3-A9C5-05DBEC867C85Q44208714-F70EDCBB-7CFE-48CF-A25E-0967A602654DQ44326435-9323FD88-D1D5-40CA-881C-3C58B3255AE6Q44444458-6E6E29DE-89D3-429D-BB7B-07150745526EQ44478616-33AEEC94-715B-4B01-B350-0ED222CFE7C3Q44731904-BCF6FA29-06A0-47F9-9037-BD8DE38E308BQ46608518-88ACF013-8F3A-4BC5-8885-0D4C885863AEQ47693056-23CC2FA6-BC9A-44C9-B6A6-E9EDB8BBBA2AQ48105703-899ABB23-58C3-40F2-B69D-950F1AD3F63EQ48151836-4D2D6421-5E86-46B0-A6C4-125F60991EE6Q51698198-B8BFD6E5-4068-4307-81E3-AE0C3C5F717DQ52603556-E98FD65E-BA27-4028-A90D-A64B55432471Q55290441-84DD126A-21A8-40D3-BB36-36E6CB6F2876Q55417882-5AA34BDF-3347-4CA3-85DB-9BA4B9376BB7Q56962190-6A09F177-8010-42BC-8E12-C3231C37FA3FQ57024729-36B30EDF-5BE0-43F8-A1BA-C1BF73A5143F
P2860
Responsiveness of the trigeminovascular system to nitroglycerine in cluster headache patients.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Responsiveness of the trigemin ...... in cluster headache patients.
@en
Responsiveness of the trigemin ...... in cluster headache patients.
@nl
type
label
Responsiveness of the trigemin ...... in cluster headache patients.
@en
Responsiveness of the trigemin ...... in cluster headache patients.
@nl
prefLabel
Responsiveness of the trigemin ...... in cluster headache patients.
@en
Responsiveness of the trigemin ...... in cluster headache patients.
@nl
P2093
P356
P1433
P1476
Responsiveness of the trigemin ...... in cluster headache patients.
@en
P2093
Alessandri M
Fanciullacci M
Marabini S
Sicuteri R
P304
P356
10.1093/BRAIN/120.2.283
P407
P478
120 ( Pt 2)
P577
1997-02-01T00:00:00Z